Primary tumour mutant p53 gene protein and epidermal growth factor receptor expression and doxorubicin plus ifosfamide for recurrent breast cancer.

Subjects

Subjects :

Adult
Breast Neoplasms drug therapy
Doxorubicin administration & dosage
ErbB Receptors physiology
Female
Gene Expression genetics
Genes, p53 genetics
Humans
Ifosfamide administration & dosage
Mesna administration & dosage
Mutation
Prognosis
Retrospective Studies
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Breast Neoplasms genetics
ErbB Receptors genetics
Tumor Suppressor Protein p53 genetics

Details

Language :

English

ISSN :

0923-7534

Volume :

3

Issue :

3

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Report

Accession number :

1586628

Full Text :

https://doi.org/10.1093/oxfordjournals.annonc.a058164